These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20674743)

  • 1. MS and the B cell controversy.
    Cross AH; Waubant E
    Biochim Biophys Acta; 2011 Feb; 1812(2):231-8. PubMed ID: 20674743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of antibodies in multiple sclerosis.
    Weber MS; Hemmer B; Cepok S
    Biochim Biophys Acta; 2011 Feb; 1812(2):239-45. PubMed ID: 20600871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cells and multiple sclerosis.
    Franciotta D; Salvetti M; Lolli F; Serafini B; Aloisi F
    Lancet Neurol; 2008 Sep; 7(9):852-8. PubMed ID: 18703007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients.
    Cross AH; Stark JL; Lauber J; Ramsbottom MJ; Lyons JA
    J Neuroimmunol; 2006 Nov; 180(1-2):63-70. PubMed ID: 16904756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More to come: humoral immune responses in MS.
    Dobson R; Meier UC; Giovannoni G
    J Neuroimmunol; 2011 Dec; 240-241():13-21. PubMed ID: 22019113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab combination therapy in relapsing multiple sclerosis.
    Cross AH; Klein RS; Piccio L
    Ther Adv Neurol Disord; 2012 Nov; 5(6):311-9. PubMed ID: 23139702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab in a patient with multiple sclerosis--effect on B cells, plasma cells and intrathecal IgG synthesis.
    Petereit HF; Moeller-Hartmann W; Reske D; Rubbert A
    Acta Neurol Scand; 2008 Jun; 117(6):399-403. PubMed ID: 18031564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs in clinical development for multiple sclerosis: focusing on anti-CD20 antibodies.
    Gasperini C; Haggiag S; Ruggieri S
    Expert Opin Investig Drugs; 2013 Oct; 22(10):1243-53. PubMed ID: 23855792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epitopes on myelin proteins recognized by autoantibodies present in multiple sclerosis patients].
    Jaśkiewicz E
    Postepy Hig Med Dosw (Online); 2004; 58():472-82. PubMed ID: 15765008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciphering the Role of B Cells in Multiple Sclerosis-Towards Specific Targeting of Pathogenic Function.
    Lehmann-Horn K; Kinzel S; Weber MS
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28946620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperation of B cells and T cells in the pathogenesis of multiple sclerosis.
    Weber MS; Hemmer B
    Results Probl Cell Differ; 2010; 51():115-26. PubMed ID: 19582406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin-specific antibodies.
    von Büdingen HC; Harrer MD; Kuenzle S; Meier M; Goebels N
    Eur J Immunol; 2008 Jul; 38(7):2014-23. PubMed ID: 18521957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of multiple sclerosis with anti-CD20 antibodies.
    Barun B; Bar-Or A
    Clin Immunol; 2012 Jan; 142(1):31-7. PubMed ID: 21555250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical stabilization and effective B-lymphocyte depletion in the cerebrospinal fluid and peripheral blood of a patient with fulminant relapsing-remitting multiple sclerosis.
    Stüve O; Cepok S; Elias B; Saleh A; Hartung HP; Hemmer B; Kieseier BC
    Arch Neurol; 2005 Oct; 62(10):1620-3. PubMed ID: 16216948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of rituximab in the treatment of ANCA-associated systemic vasculitis].
    Roccatello D; Vangelista A; Pani A
    G Ital Nefrol; 2011; 28(5):474-88. PubMed ID: 22028261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Charcot Lecture | beating MS: a story of B cells, with twists and turns.
    Hauser SL
    Mult Scler; 2015 Jan; 21(1):8-21. PubMed ID: 25480864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progress in unravelling the etiology of multiple sclerosis].
    Matsui M
    Rinsho Shinkeigaku; 2008 Nov; 48(11):849-52. PubMed ID: 19198098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls.
    Sun JB; Olsson T; Wang WZ; Xiao BG; Kostulas V; Fredrikson S; Ekre HP; Link H
    Eur J Immunol; 1991 Jun; 21(6):1461-8. PubMed ID: 1710567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
    Bar-Or A; Fawaz L; Fan B; Darlington PJ; Rieger A; Ghorayeb C; Calabresi PA; Waubant E; Hauser SL; Zhang J; Smith CH
    Ann Neurol; 2010 Apr; 67(4):452-61. PubMed ID: 20437580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE).
    Ziemssen T; Ziemssen F
    Autoimmun Rev; 2005 Sep; 4(7):460-7. PubMed ID: 16137612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.